<VariationArchive VariationID="17753" VariationName="NM_000342.4(SLC4A1):c.1199_1225del (p.Ala400_Ala408del)" VariationType="Deletion" Accession="VCV000017753" Version="20" RecordType="classified" NumberOfSubmissions="10" NumberOfSubmitters="9" DateLastUpdated="2024-03-30" DateCreated="2018-04-09" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="32792" VariationID="17753">
      <GeneList>
        <Gene Symbol="SLC4A1" FullName="solute carrier family 4 member 1 (Diego blood group)" GeneID="6521" HGNC_ID="HGNC:11027" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="44248390" stop="44268135" display_start="44248390" display_stop="44268135" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="42325757" stop="42345501" display_start="42325757" display_stop="42345501" Strand="-" />
          </Location>
          <OMIM>109270</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000342.4(SLC4A1):c.1199_1225del (p.Ala400_Ala408del)</Name>
      <CanonicalSPDI>NC_000017.11:44258042:CGGCAGCCAGGACCTGGGGGCTGAATGC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q21.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="44258043" stop="44258069" display_start="44258043" display_stop="44258069" variantLength="27" positionVCF="44258042" referenceAlleleVCF="ACGGCAGCCAGGACCTGGGGGCTGAATG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="42335411" stop="42335437" display_start="42335411" display_stop="42335437" variantLength="27" positionVCF="42335410" referenceAlleleVCF="ACGGCAGCCAGGACCTGGGGGCTGAATG" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.42335412_42335438del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.42335412_42335438del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.44258044_44258070del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.44258044_44258070del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007498.1" sequenceAccession="NG_007498" sequenceVersion="1" change="g.15066_15092del">
            <Expression>NG_007498.1:g.15066_15092del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000342.4" sequenceAccession="NM_000342" sequenceVersion="4" change="c.1199_1225del" MANESelect="true">
            <Expression>NM_000342.4:c.1199_1225del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000333.1" sequenceAccession="NP_000333" sequenceVersion="1" change="p.Ala400_Ala408del">
            <Expression>NP_000333.1:p.Ala400_Ala408del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_803" sequenceAccession="LRG_803">
            <Expression>LRG_803:g.15066_15092del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_803t1" sequenceAccession="LRG_803t1">
            <Expression>LRG_803t1:c.1199_1225del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_803p1" sequenceAccession="LRG_803p1" change="p.Ala400_Ala408del">
            <Expression>LRG_803p1:p.Ala400_Ala408del</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000342.3" sequenceAccession="NM_000342" sequenceVersion="3" change="c.1199_1225del27">
            <Expression>NM_000342.3:c.1199_1225del27</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA213002" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="109270.0002" DB="OMIM" />
        <XRef Type="rs" ID="769664228" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 1737855 Fig. 2 to determine the location of this allele on the current reference sequence.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000342.4(SLC4A1):c.1199_1225del (p.Ala400_Ala408del) AND Southeast Asian ovalocytosis" Accession="RCV000019329" Version="27">
        <ClassifiedConditionList TraitSetID="13437">
          <ClassifiedCondition DB="MedGen" ID="C1862322">Southeast Asian ovalocytosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000342.4(SLC4A1):c.1199_1225del (p.Ala400_Ala408del) AND Malaria, cerebral, resistance to" Accession="RCV000019330" Version="32">
        <ClassifiedConditionList TraitSetID="3723">
          <ClassifiedCondition DB="MedGen" ID="C1969379">Malaria, cerebral, resistance to</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2009-03-01" SubmissionCount="1">protective</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000342.4(SLC4A1):c.1199_1225del (p.Ala400_Ala408del) AND not provided" Accession="RCV001377074" Version="13">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-12-21" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000342.4(SLC4A1):c.1199_1225del (p.Ala400_Ala408del) AND multiple conditions" Accession="RCV001536118" Version="4">
        <ClassifiedConditionList TraitSetID="46920">
          <ClassifiedCondition DB="MedGen" ID="CN280572">Autosomal dominant distal renal tubular acidosis</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1292286">BLOOD GROUP--DIEGO SYSTEM</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1832168">BLOOD GROUP--FROESE</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1832169">BLOOD GROUP--SWANN SYSTEM</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1862191">BLOOD GROUP--WALDNER TYPE</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1862190">BLOOD GROUP--WRIGHT ANTIGEN</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1861453">Cryohydrocytosis</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C2675212">Hereditary spherocytosis type 4</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1970028">Malaria, susceptibility to</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C5436235">Renal tubular acidosis, distal, 4, with hemolytic anemia</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1862322">Southeast Asian ovalocytosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-01-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000342.4(SLC4A1):c.1199_1225del (p.Ala400_Ala408del) AND Renal tubular acidosis, distal, 4, with hemolytic anemia" Accession="RCV001807735" Version="1">
        <ClassifiedConditionList TraitSetID="5859">
          <ClassifiedCondition DB="MedGen" ID="C5436235">Renal tubular acidosis, distal, 4, with hemolytic anemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-05-19" SubmissionCount="2">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000342.4(SLC4A1):c.1199_1225del (p.Ala400_Ala408del) AND Distal renal tubular acidosis" Accession="RCV001849272" Version="2">
        <ClassifiedConditionList TraitSetID="43941">
          <ClassifiedCondition DB="MedGen" ID="C1704380">Distal renal tubular acidosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2019-10-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-21" NumberOfSubmissions="10" NumberOfSubmitters="9" DateCreated="2018-04-09" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10403343</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1378323</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">14618420</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16107207</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1722314</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1737855</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19229254</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20421175</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2146504</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24652967</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28188436</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31672324</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31959358</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">6338046</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7689982</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7919393</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7949112</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8434259</ID>
        </Citation>
        <DescriptionHistory Dated="2021-06-14">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2021-05-10">
          <Description>Pathogenic, protective</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="43941" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="26746" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Distal renal tubular acidosis</ElementValue>
                <XRef ID="HP:0008341" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0015827" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4667" />
                <XRef ID="4667" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="18" DB="Orphanet" />
              <XRef ID="C1704380" DB="MedGen" />
              <XRef ID="MONDO:0015827" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS179800" DB="OMIM" />
              <XRef Type="primary" ID="HP:0008341" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="46920" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5855" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Autosomal dominant distal renal tubular acidosis</ElementValue>
                <XRef ID="MONDO:0008368" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">RTA, classic type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">RTA, gradient type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Renal tubular acidosis 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">RTA, distal type, autosomal dominant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Renal Tubular Acidosis, Type I</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">RENAL TUBULAR ACIDOSIS, DISTAL, 1</ElementValue>
                <XRef Type="MIM" ID="179800" DB="OMIM" />
                <XRef Type="Allelic variant" ID="109270.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="109270.0025" DB="OMIM" />
                <XRef Type="Allelic variant" ID="109270.0020" DB="OMIM" />
                <XRef Type="Allelic variant" ID="109270.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="109270.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="109270.0012" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DRTA1</ElementValue>
                <XRef Type="MIM" ID="179800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Individuals with hereditary distal renal tubular acidosis (dRTA) typically present in infancy with failure to thrive, although later presentations can occur, especially in individuals with autosomal dominant SLC4A1-dRTA. Initial clinical manifestations can also include emesis, polyuria, polydipsia, constipation, diarrhea, decreased appetite, and episodes of dehydration. Electrolyte manifestations include hyperchloremic non-anion gap metabolic acidosis and hypokalemia. Renal complications of dRTA include nephrocalcinosis, nephrolithiasis, medullary cysts, and impaired renal function. Additional manifestations include bone demineralization (rickets, osteomalacia), growth deficiency, sensorineural hearing loss (in ATP6V0A4-, ATP6V1B1-, and FOXI1-dRTA), and hereditary hemolytic anemia (in some individuals with SLC4A1-dRTA).</Attribute>
                <XRef ID="NBK547595" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4668" />
                <XRef ID="4668" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31600044</ID>
                <ID Source="BookShelf">NBK547595</ID>
              </Citation>
              <XRef ID="93608" DB="Orphanet" />
              <XRef ID="CN280572" DB="MedGen" />
              <XRef ID="MONDO:0008368" DB="MONDO" />
              <XRef Type="MIM" ID="179800" DB="OMIM" />
            </Trait>
            <Trait ID="5856" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Renal tubular acidosis, distal, 4, with hemolytic anemia</ElementValue>
                <XRef ID="MONDO:0012700" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Renal tubular acidosis, distal, with hemolytic anemia</ElementValue>
                <XRef ID="Renal+tubular+acidosis%2C+distal%2C+with+hemolytic+anemia/9218" DB="Genetic Alliance" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Individuals with hereditary distal renal tubular acidosis (dRTA) typically present in infancy with failure to thrive, although later presentations can occur, especially in individuals with autosomal dominant SLC4A1-dRTA. Initial clinical manifestations can also include emesis, polyuria, polydipsia, constipation, diarrhea, decreased appetite, and episodes of dehydration. Electrolyte manifestations include hyperchloremic non-anion gap metabolic acidosis and hypokalemia. Renal complications of dRTA include nephrocalcinosis, nephrolithiasis, medullary cysts, and impaired renal function. Additional manifestations include bone demineralization (rickets, osteomalacia), growth deficiency, sensorineural hearing loss (in ATP6V0A4-, ATP6V1B1-, and FOXI1-dRTA), and hereditary hemolytic anemia (in some individuals with SLC4A1-dRTA).</Attribute>
                <XRef ID="NBK547595" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12354" />
                <XRef ID="12354" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31600044</ID>
                <ID Source="BookShelf">NBK547595</ID>
              </Citation>
              <XRef ID="93610" DB="Orphanet" />
              <XRef ID="C5436235" DB="MedGen" />
              <XRef ID="MONDO:0012700" DB="MONDO" />
              <XRef Type="MIM" ID="611590" DB="OMIM" />
            </Trait>
            <Trait ID="499" Type="BloodGroup">
              <Name>
                <ElementValue Type="Alternate">SWANN BLOOD GROUP</ElementValue>
                <XRef Type="MIM" ID="601550" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">BLOOD GROUP--SWANN SYSTEM</ElementValue>
                <XRef Type="MIM" ID="601550" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SW</ElementValue>
                <XRef Type="MIM" ID="601550" DB="OMIM" />
              </Symbol>
              <XRef ID="C1832169" DB="MedGen" />
              <XRef Type="MIM" ID="601550" DB="OMIM" />
            </Trait>
            <Trait ID="613" Type="BloodGroup">
              <Name>
                <ElementValue Type="Alternate">WALDNER BLOOD GROUP ANTIGEN</ElementValue>
                <XRef Type="MIM" ID="112010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="109270.0011" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">BLOOD GROUP--WALDNER TYPE</ElementValue>
                <XRef ID="BLOOD+GROUP--WALDNER+TYPE/7845" DB="Genetic Alliance" />
                <XRef Type="MIM" ID="112010" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">WD</ElementValue>
                <XRef Type="MIM" ID="112010" DB="OMIM" />
              </Symbol>
              <XRef ID="C1862191" DB="MedGen" />
              <XRef Type="MIM" ID="112010" DB="OMIM" />
            </Trait>
            <Trait ID="1033" Type="BloodGroup">
              <Name>
                <ElementValue Type="Alternate">FROESE BLOOD GROUP ANTIGEN</ElementValue>
                <XRef Type="MIM" ID="601551" DB="OMIM" />
                <XRef Type="Allelic variant" ID="109270.0029" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">BLOOD GROUP--FROESE</ElementValue>
                <XRef Type="MIM" ID="601551" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FR</ElementValue>
                <XRef Type="MIM" ID="601551" DB="OMIM" />
              </Symbol>
              <XRef ID="C1832168" DB="MedGen" />
              <XRef Type="MIM" ID="601551" DB="OMIM" />
            </Trait>
            <Trait ID="1038" Type="BloodGroup">
              <Name>
                <ElementValue Type="Preferred">BLOOD GROUP--WRIGHT ANTIGEN</ElementValue>
                <XRef Type="MIM" ID="112050" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">WR</ElementValue>
                <XRef Type="MIM" ID="112050" DB="OMIM" />
              </Symbol>
              <XRef ID="C1862190" DB="MedGen" />
              <XRef Type="MIM" ID="112050" DB="OMIM" />
            </Trait>
            <Trait ID="4682" Type="BloodGroup">
              <Name>
                <ElementValue Type="Alternate">BLOOD GROUP, DIEGO SYSTEM</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">BLOOD GROUP--DIEGO SYSTEM</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DI</ElementValue>
                <XRef Type="MIM" ID="110500" DB="OMIM" />
              </Symbol>
              <XRef ID="C1292286" DB="MedGen" />
              <XRef Type="MIM" ID="110500" DB="OMIM" />
            </Trait>
            <Trait ID="5819" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Pseudohyperkalemia Cardiff</ElementValue>
                <XRef ID="Pseudohyperkalemia+Cardiff/6031" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CRYOHYDROCYTOSIS DUE TO BAND 3 HEMEL</ElementValue>
                <XRef Type="Allelic variant" ID="109270.0033" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CRYOHYDROCYTOSIS DUE TO BAND 3 HURSTPIERPOINT</ElementValue>
                <XRef Type="Allelic variant" ID="109270.0034" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CRYOHYDROCYTOSIS DUE TO BAND 3 BLACKBURN</ElementValue>
                <XRef Type="Allelic variant" ID="109270.0035" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary cryohydrocytosis with normal stomatin</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Stomatocytosis, cold-sensitive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Cryohydrocytosis</ElementValue>
                <XRef ID="MONDO:0008494" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CHC</ElementValue>
                <XRef Type="MIM" ID="185020" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10184" />
                <XRef ID="10184" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="398088" DB="Orphanet" />
              <XRef ID="C1861453" DB="MedGen" />
              <XRef ID="MONDO:0008494" DB="MONDO" />
              <XRef Type="MIM" ID="185020" DB="OMIM" />
            </Trait>
            <Trait ID="3251" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Southeast Asian ovalocytosis</ElementValue>
                <XRef ID="MONDO:0008165" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HE, STOMATOCYTIC</ElementValue>
                <XRef Type="MIM" ID="166900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Elliptocytosis 4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Stomatocytic elliptocytosis, hereditary</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ovalocytosis, Malaysian-Melanesian-Filipino type</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SAO</ElementValue>
                <XRef Type="MIM" ID="166900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EL4</ElementValue>
                <XRef Type="MIM" ID="166900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16867" />
                <XRef ID="16867" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="98868" DB="Orphanet" />
              <XRef ID="C1862322" DB="MedGen" />
              <XRef ID="MONDO:0008165" DB="MONDO" />
              <XRef Type="MIM" ID="166900" DB="OMIM" />
            </Trait>
            <Trait ID="10300" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Malaria, susceptibility to</ElementValue>
                <XRef ID="MONDO:0021024" DB="MONDO" />
              </Name>
              <XRef ID="673" DB="Orphanet" />
              <XRef ID="C1970028" DB="MedGen" />
              <XRef ID="MONDO:0021024" DB="MONDO" />
              <XRef Type="MIM" ID="611162" DB="OMIM" />
            </Trait>
            <Trait ID="3813" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">SLC4A1-Related Spherocytosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spherocytosis type 4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary spherocytosis type 4</ElementValue>
                <XRef ID="MONDO:0012981" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SPH4</ElementValue>
                <XRef Type="MIM" ID="612653" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HS4</ElementValue>
                <XRef Type="MIM" ID="612653" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15576" />
                <XRef ID="15576" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="822" DB="Orphanet" />
              <XRef ID="C2675212" DB="MedGen" />
              <XRef ID="MONDO:0012981" DB="MONDO" />
              <XRef Type="MIM" ID="612653" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13437" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3251" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Southeast Asian ovalocytosis</ElementValue>
                <XRef ID="MONDO:0008165" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HE, STOMATOCYTIC</ElementValue>
                <XRef Type="MIM" ID="166900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Elliptocytosis 4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Stomatocytic elliptocytosis, hereditary</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ovalocytosis, Malaysian-Melanesian-Filipino type</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SAO</ElementValue>
                <XRef Type="MIM" ID="166900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EL4</ElementValue>
                <XRef Type="MIM" ID="166900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16867" />
                <XRef ID="16867" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="98868" DB="Orphanet" />
              <XRef ID="C1862322" DB="MedGen" />
              <XRef ID="MONDO:0008165" DB="MONDO" />
              <XRef Type="MIM" ID="166900" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5859" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5856" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Renal tubular acidosis, distal, 4, with hemolytic anemia</ElementValue>
                <XRef ID="MONDO:0012700" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Renal tubular acidosis, distal, with hemolytic anemia</ElementValue>
                <XRef ID="Renal+tubular+acidosis%2C+distal%2C+with+hemolytic+anemia/9218" DB="Genetic Alliance" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Individuals with hereditary distal renal tubular acidosis (dRTA) typically present in infancy with failure to thrive, although later presentations can occur, especially in individuals with autosomal dominant SLC4A1-dRTA. Initial clinical manifestations can also include emesis, polyuria, polydipsia, constipation, diarrhea, decreased appetite, and episodes of dehydration. Electrolyte manifestations include hyperchloremic non-anion gap metabolic acidosis and hypokalemia. Renal complications of dRTA include nephrocalcinosis, nephrolithiasis, medullary cysts, and impaired renal function. Additional manifestations include bone demineralization (rickets, osteomalacia), growth deficiency, sensorineural hearing loss (in ATP6V0A4-, ATP6V1B1-, and FOXI1-dRTA), and hereditary hemolytic anemia (in some individuals with SLC4A1-dRTA).</Attribute>
                <XRef ID="NBK547595" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12354" />
                <XRef ID="12354" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31600044</ID>
                <ID Source="BookShelf">NBK547595</ID>
              </Citation>
              <XRef ID="93610" DB="Orphanet" />
              <XRef ID="C5436235" DB="MedGen" />
              <XRef ID="MONDO:0012700" DB="MONDO" />
              <XRef Type="MIM" ID="611590" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3723" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="9209" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Malaria, cerebral, resistance to</ElementValue>
              </Name>
              <XRef ID="C1969379" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="39619" SubmissionDate="2020-08-27" DateLastUpdated="2020-08-29" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="109270.0002_OVALOCYTOSIS, SOUTHEAST ASIAN" title="SLC4A1, 27-BP DEL, CODONS 400-408_OVALOCYTOSIS, SOUTHEAST ASIAN" />
        <ClinVarAccession Accession="SCV000039619" DateUpdated="2020-08-29" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2009-03-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Following up on the demonstration by Liu et al. (1990) that a structurally and functionally abnormal band 3 protein shows absolute linkage with the SAO phenotype (166900), Jarolim et al. (1991) demonstrated that the EPB3 gene in these cases contains a 27-bp deletion, resulting in deletion of 9 amino acids (codons 400-408) in the boundary of cytoplasmic and membrane domains of the band 3 protein. The defect was detected in all 30 ovalocytic subjects from Malaysia, the Philippines, and 2 unrelated coastal regions of Papua New Guinea, whereas it was absent in all 30 controls from Southeast Asia and 20 subjects of different ethnic origin from the United States. The lys56-to-glu mutation (109270.0001) was also found in all SAO subjects; however, it was detected in 5 of 50 control subjects as well, suggesting that it represents a linked polymorphism.</Attribute>
              <Citation>
                <ID Source="PubMed">2146504</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">1378323</ID>
              </Citation>
              <XRef DB="OMIM" ID="166900" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Mohandas et al. (1992) likewise demonstrated the deletion of amino acids 400-408 in the boundary between the cytoplasmic and the first transmembrane domains of band 3. The biophysical consequences of the mutation was a marked decrease in lateral mobility of band 3 and an increase in membrane rigidity. Mohandas et al. (1992) suggested that the mutation induces a conformational change in the cytoplasmic domain of band 3, leading to its entanglement in the skeletal protein network. This entanglement inhibits the normal unwinding and stretching of the spectrin tetramers necessary for membrane extension, leading to increased rigidity.</Attribute>
              <Citation>
                <ID Source="PubMed">1737855</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">The same deletion of 9 amino acids was found by Tanner et al. (1991) in a Mauritian Indian and by Ravindranath et al. (1994) in an African American mother and daughter. All cases of SAO had been associated with the Memphis-1 polymorphism (109270.0001), which is found in all populations but is present at higher frequency in American Indian and African American populations. However, SAO had not previously been identified in African Americans.</Attribute>
              <Citation>
                <ID Source="PubMed">8434259</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">7919393</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">The band 3 deletion in Southeast Asian ovalocytosis may prevent cerebral malaria (611162), but it exacerbates malarial anemia and may also increase acidosis, a major determinant of mortality in malaria. Allen et al. (1999) undertook a case-control study of children admitted to hospital in a malarious area of Papua New Guinea. The 24-bp deletion, detected by PCR, was present in 0 of 68 children with cerebral malaria, compared with 6 (8.8%) of 68 matched community controls. Median hemoglobin levels were 1.2 g/dl lower in malaria cases with Southeast Asian ovalocytosis than in controls (P = 0.035), but acidosis was not affected. The band 3 protein mediates the cytoadherence of parasitized erythrocytes in vitro. The remarkable protection that the SAO variant affords against cerebral malaria may offer a valuable approach to a better understanding of the mechanisms of adherence of parasitized erythrocytes to vascular endothelium and the pathogenesis of cerebral malaria.</Attribute>
              <Citation>
                <ID Source="PubMed">10403343</ID>
              </Citation>
              <XRef DB="OMIM" ID="611162" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">The abnormal SAO protein does not mediate chloride transport (Groves et al., 1993), and homozygosity for the 9-amino acid deletion is apparently lethal (Liu et al., 1994).</Attribute>
              <Citation>
                <ID Source="PubMed">7689982</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">7949112</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Yusoff et al. (2003) examined the incidence of SAO in Malays in Kelantan, Malaysia, who had distal renal tubular acidosis. SAO was identified in 18 of the 22 distal renal tubular acidosis patients (81.8%), but in only 2 of the 50 controls (4%). Yusoff et al. (2003) referred to the band 3 variant as a 27-nt deletion.</Attribute>
              <Citation>
                <ID Source="PubMed">14618420</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a population-based study of 19 individuals each from Japan, Taiwan, and Indonesia, Wilder et al. (2009) found the 27-bp deletion associated with the SAO trait in 4 of the Indonesian samples only. These 4 SAO chromosomes also carried the Memphis variant (109270.0001). The haplotype associated with the 27-bp deletion was also found in Japanese samples, but not in Taiwanese samples, which was a surprising finding since Taiwan was thought to be part of the Austronesian population expansion. The findings indicated that chromosomes related to Indonesian SAO alleles are not a major component of genetic diversity among aboriginal Taiwanese, and suggested that the SLC4A1 gene is subject to natural selection.</Attribute>
              <Citation>
                <ID Source="PubMed">19229254</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC4A1" />
          </GeneList>
          <Name>SLC4A1, 27-BP DEL, CODONS 400-408</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">27-BP DEL, CODONS 400-408</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="109270.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">OVALOCYTOSIS, SOUTHEAST ASIAN</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="39620" SubmissionDate="2020-08-27" DateLastUpdated="2020-08-29" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="109270.0002_MALARIA, CEREBRAL, RESISTANCE TO" title="SLC4A1, 27-BP DEL, CODONS 400-408_MALARIA, CEREBRAL, RESISTANCE TO" />
        <ClinVarAccession Accession="SCV000039620" DateUpdated="2020-08-29" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2009-03-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>protective</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Following up on the demonstration by Liu et al. (1990) that a structurally and functionally abnormal band 3 protein shows absolute linkage with the SAO phenotype (166900), Jarolim et al. (1991) demonstrated that the EPB3 gene in these cases contains a 27-bp deletion, resulting in deletion of 9 amino acids (codons 400-408) in the boundary of cytoplasmic and membrane domains of the band 3 protein. The defect was detected in all 30 ovalocytic subjects from Malaysia, the Philippines, and 2 unrelated coastal regions of Papua New Guinea, whereas it was absent in all 30 controls from Southeast Asia and 20 subjects of different ethnic origin from the United States. The lys56-to-glu mutation (109270.0001) was also found in all SAO subjects; however, it was detected in 5 of 50 control subjects as well, suggesting that it represents a linked polymorphism.</Attribute>
              <Citation>
                <ID Source="PubMed">2146504</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">1378323</ID>
              </Citation>
              <XRef DB="OMIM" ID="166900" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Mohandas et al. (1992) likewise demonstrated the deletion of amino acids 400-408 in the boundary between the cytoplasmic and the first transmembrane domains of band 3. The biophysical consequences of the mutation was a marked decrease in lateral mobility of band 3 and an increase in membrane rigidity. Mohandas et al. (1992) suggested that the mutation induces a conformational change in the cytoplasmic domain of band 3, leading to its entanglement in the skeletal protein network. This entanglement inhibits the normal unwinding and stretching of the spectrin tetramers necessary for membrane extension, leading to increased rigidity.</Attribute>
              <Citation>
                <ID Source="PubMed">1737855</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">The same deletion of 9 amino acids was found by Tanner et al. (1991) in a Mauritian Indian and by Ravindranath et al. (1994) in an African American mother and daughter. All cases of SAO had been associated with the Memphis-1 polymorphism (109270.0001), which is found in all populations but is present at higher frequency in American Indian and African American populations. However, SAO had not previously been identified in African Americans.</Attribute>
              <Citation>
                <ID Source="PubMed">8434259</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">7919393</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">The band 3 deletion in Southeast Asian ovalocytosis may prevent cerebral malaria (611162), but it exacerbates malarial anemia and may also increase acidosis, a major determinant of mortality in malaria. Allen et al. (1999) undertook a case-control study of children admitted to hospital in a malarious area of Papua New Guinea. The 24-bp deletion, detected by PCR, was present in 0 of 68 children with cerebral malaria, compared with 6 (8.8%) of 68 matched community controls. Median hemoglobin levels were 1.2 g/dl lower in malaria cases with Southeast Asian ovalocytosis than in controls (P = 0.035), but acidosis was not affected. The band 3 protein mediates the cytoadherence of parasitized erythrocytes in vitro. The remarkable protection that the SAO variant affords against cerebral malaria may offer a valuable approach to a better understanding of the mechanisms of adherence of parasitized erythrocytes to vascular endothelium and the pathogenesis of cerebral malaria.</Attribute>
              <Citation>
                <ID Source="PubMed">10403343</ID>
              </Citation>
              <XRef DB="OMIM" ID="611162" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">The abnormal SAO protein does not mediate chloride transport (Groves et al., 1993), and homozygosity for the 9-amino acid deletion is apparently lethal (Liu et al., 1994).</Attribute>
              <Citation>
                <ID Source="PubMed">7689982</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">7949112</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Yusoff et al. (2003) examined the incidence of SAO in Malays in Kelantan, Malaysia, who had distal renal tubular acidosis. SAO was identified in 18 of the 22 distal renal tubular acidosis patients (81.8%), but in only 2 of the 50 controls (4%). Yusoff et al. (2003) referred to the band 3 variant as a 27-nt deletion.</Attribute>
              <Citation>
                <ID Source="PubMed">14618420</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a population-based study of 19 individuals each from Japan, Taiwan, and Indonesia, Wilder et al. (2009) found the 27-bp deletion associated with the SAO trait in 4 of the Indonesian samples only. These 4 SAO chromosomes also carried the Memphis variant (109270.0001). The haplotype associated with the 27-bp deletion was also found in Japanese samples, but not in Taiwanese samples, which was a surprising finding since Taiwan was thought to be part of the Austronesian population expansion. The findings indicated that chromosomes related to Indonesian SAO alleles are not a major component of genetic diversity among aboriginal Taiwanese, and suggested that the SLC4A1 gene is subject to natural selection.</Attribute>
              <Citation>
                <ID Source="PubMed">19229254</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC4A1" />
          </GeneList>
          <Name>SLC4A1, 27-BP DEL, CODONS 400-408</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">27-BP DEL, CODONS 400-408</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="109270.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">MALARIA, CEREBRAL, RESISTANCE TO</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4124069" SubmissionDate="2022-03-21" DateLastUpdated="2022-03-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="NM_000342.2:c.1199_1225del|Orphanet:18" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002106696" DateUpdated="2022-03-28" DateCreated="2022-03-28" Type="SCV" Version="1" SubmitterName="Yale Center for Mendelian Genomics, Yale University" OrgID="506150" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-10-22">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">31959358</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000342.2:c.1199_1225del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA18" />
          </Trait>
        </TraitSet>
        <StudyName>Yale Center for Mendelian Genomics</StudyName>
        <StudyDescription>The Yale Center for Mendelian Genomics is one of the national centers created by the NIH to study the genetics of rare inherited diseases.</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>SUB11200512</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3448310" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2021-07-18">
        <ClinVarSubmissionID localKey="NM_000342.4:c.1199_1225del|OMIM:110500;112010;112050;166900;179800;185020;601550;601551;611162;611590;612653" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001752834" DateUpdated="2022-12-31" DateCreated="2021-07-18" Type="SCV" Version="2" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000342.4:c.1199_1225del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="BloodGroup">
            <XRef DB="OMIM" ID="110500" Type="MIM" />
          </Trait>
          <Trait Type="BloodGroup">
            <XRef DB="OMIM" ID="112010" Type="MIM" />
          </Trait>
          <Trait Type="BloodGroup">
            <XRef DB="OMIM" ID="112050" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="166900" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="179800" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="185020" Type="MIM" />
          </Trait>
          <Trait Type="BloodGroup">
            <XRef DB="OMIM" ID="601550" Type="MIM" />
          </Trait>
          <Trait Type="BloodGroup">
            <XRef DB="OMIM" ID="601551" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="611162" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="611590" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="612653" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
          <SubmissionName>SUB9977930</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7331174" SubmissionDate="2023-04-04" DateLastUpdated="2023-05-06" DateCreated="2023-05-06">
        <ClinVarSubmissionID localKey="NM_000342.3:c.1199_1225del|OMIM:166900" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV003921806" DateUpdated="2023-05-06" DateCreated="2023-05-06" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>- In-frame insertion/deletion in a non-repetitive region that has moderate conservation. - Variant is present in gnomAD (v2) &lt;0.01 for a recessive condition (13 heterozygotes, 0 homozygotes). - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been observed in many heterozygous individuals with SA type ovalocytosis, and is highly prevalent within South Asian populations (PMIDs: 30124986, 19229254, 7949112). Additionally, carriers of this variant have some resistance to all forms of malaria (PMID: 31364155, OMIM). It is highly likely to be lethal in homozygosity, where rare survivors demonstrate severe anaemia, hydrops and distal renal tubular acidosis (PMID: 24652967). - Strong phenotype match for this individual. Additional information: - Dominant negative and loss of function are known mechanisms of disease in this gene and are associated with SLC4A1-related disease. Spherocytosis type 4 (MIM#612653) is caused by variants with a loss of function mechanism. Cryohydrocytosis (MIM#185020), distal renal tubular acidosis (dRTA) (MIM#1179800), dRTA 4 with hemolytic anemia (MIM#611590) and SA type ovalocytosis (SAO) (MIM#166900) are caused by variants with either a loss of function, or dominant negative mechanism (PMID: 27058983). - This gene is associated with both recessive and dominant disease. Most reports for this gene are for dominant disease, however, individuals biallelic for variants causing SAO have a more severe phenotype (OMIM, PMID: 17557941). - This variant is homozygous. - Variant is located in the annotated anion exchange transporter domain (UniProt, DECIPHER). - This variant has been shown to be both maternally and paternally inherited (biallelic) (by trio analysis).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>biparental</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC4A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000342.3:c.1199_1225del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="166900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13026601</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7535889" SubmissionDate="2023-08-16" DateLastUpdated="2023-08-26" DateCreated="2023-08-26">
        <ClinVarSubmissionID localKey="4088048_NM_000342.4:c.1199_1225del|OMIM:611590" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004027790" DateUpdated="2023-08-26" DateCreated="2023-08-26" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics, University of Leipzig Medical Center" OrgID="506086" OrganizationCategory="clinic" OrgAbbreviation="UKL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Criteria applied: PM5_STR,PM4,PM2_SUP</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000083" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001947" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC4A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000342.4:c.1199_1225del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="611590" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13762194</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3099899" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="6999504|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001574307" DateUpdated="2024-02-20" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">1722314</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">1737855</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7919393</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7949112</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14618420</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19229254</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24652967</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28188436</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31672324</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31959358</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7689982</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16107207</ID>
          </Citation>
          <Comment>This variant, c.1199_1225del, results in the deletion of 9 amino acid(s) of the SLC4A1 protein (p.Ala400_Ala408del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs769664228, gnomAD 0.02%). This variant has been observed in individual(s) with autosomal dominant ovalocytosis and/or autosomal recessive distal renal tubular acidosis (PMID: 1722314, 1737855, 7919393, 7949112, 14618420, 19229254, 24652967, 28188436, 31672324, 31959358; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 17753). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects SLC4A1 function (PMID: 7689982, 16107207). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC4A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.42335411_42335437del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3373352" SubmissionDate="2021-05-26" DateLastUpdated="2021-06-15" DateCreated="2021-06-15">
        <ClinVarSubmissionID localKey="NM_000342.3:c.1199_1225del27|Not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001712909" DateUpdated="2021-06-15" DateCreated="2021-06-15" Type="SCV" Version="1" SubmitterName="Mayo Clinic Laboratories, Mayo Clinic" OrgID="500068" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-10-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">6338046</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7949112</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10403343</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">1737855</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20421175</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24652967</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC4A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000342.3:exon 11</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>p.Ala400_Ala408del</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000342.3:c.1199_1225del27</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9741791</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4032236" SubmissionDate="2022-01-11" DateLastUpdated="2022-01-15" DateCreated="2022-01-15">
        <ClinVarSubmissionID localKey="17-42335410-ACGGCAGCCAGGACCTGGGGGCTGAATG-A" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002058603" DateUpdated="2022-01-15" DateCreated="2022-01-15" Type="SCV" Version="1" SubmitterName="3billion" OrgID="507830" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>This inframe deletion in the non-repeat region can change the length of the protein and disrupt protein function (PM4_M). The variant has been reported at least twice as pathogenic/likely pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000017753). It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.000046, PM2_M). Therefore, this variant is classified as likely pathogenic according to the recommendation of ACMG/AMP guideline.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq</NamePlatform>
              <TypePlatform>whole exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001878" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001433" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0004482" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC4A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000342.3:c.1199_1225del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="611590" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10918354</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7117135" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="8c36770b77b175459ebae32265a97ae012394020807a4933a7405692a10918e8|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003817041" DateUpdated="2024-02-04" DateCreated="2023-03-04" Type="SCV" Version="2" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000342.4:c.1199_1225del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12922107</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7535889" TraitType="Disease" MappingType="XRef" MappingValue="611590" MappingRef="OMIM">
        <MedGen CUI="C5436235" Name="Renal tubular acidosis, distal, 4, with hemolytic anemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="39620" TraitType="Disease" MappingType="Name" MappingValue="MALARIA, CEREBRAL, RESISTANCE TO" MappingRef="Alternate">
        <MedGen CUI="C1969379" Name="Malaria, cerebral, resistance to" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3448310" TraitType="BloodGroup" MappingType="XRef" MappingValue="601550" MappingRef="OMIM">
        <MedGen CUI="C1832169" Name="BLOOD GROUP--SWANN SYSTEM" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7535889" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001947" MappingRef="HP">
        <MedGen CUI="C0001126" Name="Renal tubular acidosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4032236" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001878" MappingRef="HP">
        <MedGen CUI="C0002878" Name="Hemolytic anemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3448310" TraitType="BloodGroup" MappingType="XRef" MappingValue="112050" MappingRef="OMIM">
        <MedGen CUI="C1862190" Name="BLOOD GROUP--WRIGHT ANTIGEN" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3448310" TraitType="Disease" MappingType="XRef" MappingValue="611590" MappingRef="OMIM">
        <MedGen CUI="C5436235" Name="Renal tubular acidosis, distal, 4, with hemolytic anemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7117135" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4032236" TraitType="Disease" MappingType="XRef" MappingValue="611590" MappingRef="OMIM">
        <MedGen CUI="C5436235" Name="Renal tubular acidosis, distal, 4, with hemolytic anemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3448310" TraitType="Disease" MappingType="XRef" MappingValue="166900" MappingRef="OMIM">
        <MedGen CUI="C1862322" Name="Southeast Asian ovalocytosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3448310" TraitType="BloodGroup" MappingType="XRef" MappingValue="112010" MappingRef="OMIM">
        <MedGen CUI="C1862191" Name="BLOOD GROUP--WALDNER TYPE" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4032236" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001433" MappingRef="HP">
        <MedGen CUI="C0019214" Name="Hepatosplenomegaly" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3448310" TraitType="BloodGroup" MappingType="XRef" MappingValue="601551" MappingRef="OMIM">
        <MedGen CUI="C1832168" Name="BLOOD GROUP--FROESE" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3373352" TraitType="Disease" MappingType="Name" MappingValue="Not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3448310" TraitType="Disease" MappingType="XRef" MappingValue="612653" MappingRef="OMIM">
        <MedGen CUI="C2675212" Name="Hereditary spherocytosis type 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4032236" TraitType="Finding" MappingType="XRef" MappingValue="HP:0004482" MappingRef="HP">
        <MedGen CUI="C1849075" Name="Relative macrocephaly" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3448310" TraitType="Disease" MappingType="XRef" MappingValue="611162" MappingRef="OMIM">
        <MedGen CUI="C1970028" Name="Malaria, susceptibility to" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3448310" TraitType="BloodGroup" MappingType="XRef" MappingValue="110500" MappingRef="OMIM">
        <MedGen CUI="C1292286" Name="BLOOD GROUP--DIEGO SYSTEM" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7331174" TraitType="Disease" MappingType="XRef" MappingValue="166900" MappingRef="OMIM">
        <MedGen CUI="C1862322" Name="Southeast Asian ovalocytosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3448310" TraitType="Disease" MappingType="XRef" MappingValue="179800" MappingRef="OMIM">
        <MedGen CUI="CN280572" Name="Autosomal dominant distal renal tubular acidosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3099899" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="39619" TraitType="Disease" MappingType="Name" MappingValue="OVALOCYTOSIS, SOUTHEAST ASIAN" MappingRef="Preferred">
        <MedGen CUI="C1862322" Name="Southeast Asian ovalocytosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4124069" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA18" MappingRef="Orphanet">
        <MedGen CUI="C1704380" Name="Distal renal tubular acidosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7535889" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000083" MappingRef="HP">
        <MedGen CUI="C1565489" Name="Renal insufficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3448310" TraitType="Disease" MappingType="XRef" MappingValue="185020" MappingRef="OMIM">
        <MedGen CUI="C1861453" Name="Cryohydrocytosis" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

